Literature DB >> 15322891

Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome.

Laura De Petris1, Alessandra Gianviti, Ugo Giordano, Armando Calzolari, Alberto E Tozzi, Gianfranco Rizzoni.   

Abstract

The hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure (ARF) in young children. Most patients recover from the acute phase of the illness but they may develop arterial hypertension(AH) after many years, even in the absence of signs of renal impairment during short-term follow-up. In this study, we performed casual blood pressure (BP) measurement, 24-h blood pressure monitoring (ABPM), and a Bruce walking treadmill study (ET) in 24 children (aged 5-15 years, 13 males, 11 females) with a history of HUS and normal renal function during follow-up (median 5.8 years, range 1.8-12.4 years). There were 22 children(91%) with prodromal diarrhea associated with HUS and 20 (83%) underwent dialysis during the acute illness. All children had normal casual BP measurement. Of 13 children (54%) with normal ABPM, 5 patients (38%) had an abnormal BP response during the ET study. There were 4 (58%) of the 7 patients with AH by ABPM (29%)and an abnormal BP response during ET. These findings suggest that ET could be a useful means of identifying children with a history of HUS that could be at risk of future AH even if they had normal renal function, casual BP, and ABPM during long-term follow-up. These results should be confirmed with a large prospective clinical study.

Entities:  

Mesh:

Year:  2004        PMID: 15322891     DOI: 10.1007/s00467-004-1582-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Exercise BP response in subjects with high-normal BP: exaggerated blood pressure response to exercise and risk of future hypertension in subjects with high-normal blood pressure.

Authors:  N Miyai; M Arita; I Morioka; K Miyashita; I Nishio; S Takeda
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

2.  Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping?

Authors:  J C O'Shea; M B Murphy
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

3.  Hemolytic-uremic syndrome in adolescents.

Authors:  R L Siegler; A T Pavia; J B Cook
Journal:  Arch Pediatr Adolesc Med       Date:  1997-02

4.  Exaggerated blood pressure response to dynamic exercise and risk of future hypertension.

Authors:  C E Matthews; R R Pate; K L Jackson; D S Ward; C A Macera; H W Kohl; S N Blair
Journal:  J Clin Epidemiol       Date:  1998-01       Impact factor: 6.437

5.  The hemolytic-uremic syndrome.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G E Gallo; E T Sojo
Journal:  Nephron       Date:  1973       Impact factor: 2.847

6.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

7.  Ambulatory blood pressure monitoring after recovery from hemolytic uremic syndrome.

Authors:  R T Krmar; J R Ferraris; J A Ramirez; S Ruiz; A Salomon; H M Galvez; J J Janson; C R Galarza; G Waisman
Journal:  Pediatr Nephrol       Date:  2001-10       Impact factor: 3.714

8.  Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension.

Authors:  M Middeke; J Schrader
Journal:  BMJ       Date:  1994-03-05

9.  Haemolytic-uraemic syndrome: an analysis of prognostic features.

Authors:  R S Trompeter; R Schwartz; C Chantler; M J Dillon; G B Haycock; R Kay; T M Barratt
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

10.  Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis.

Authors:  N Lingens; M Soergel; C Loirat; C Busch; B Lemmer; K Schärer
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

View more
  7 in total

1.  Blood pressure in the long-term follow-up of children with haemolytic uremic syndrome.

Authors:  T Martin Barratt; Margaret M Fitzpatrick
Journal:  Pediatr Nephrol       Date:  2005-05       Impact factor: 3.714

2.  Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome.

Authors:  Brent R Weil; Sharon P Andreoli; Deborah F Billmire
Journal:  Pediatr Nephrol       Date:  2010-04-27       Impact factor: 3.714

Review 3.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

Review 4.  Pathogenesis and prognosis of thrombotic microangiopathy.

Authors:  Masaomi Nangaku; Hiroshi Nishi; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

5.  Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.

Authors:  Catherine Monet-Didailler; Astrid Godron-Dubrasquet; Iona Madden; Yahsou Delmas; Brigitte Llanas; Jérôme Harambat
Journal:  Pediatr Nephrol       Date:  2018-10-27       Impact factor: 3.714

6.  Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.

Authors:  Mamta Puraswani; Priyanka Khandelwal; Himanshi Saini; Savita Saini; Bahadur Singh Gurjar; Aditi Sinha; Rajashri Pramod Shende; Tushar Kanti Maiti; Abhishek Kumar Singh; Uma Kanga; Uma Ali; Indira Agarwal; Kanav Anand; Narayan Prasad; Padmaraj Rajendran; Rajiv Sinha; Anil Vasudevan; Anita Saxena; Sanjay Agarwal; Pankaj Hari; Arvind Sahu; Satyajit Rath; Arvind Bagga
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

Review 7.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Johanna Scheiring; Sharon P Andreoli; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.